These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
838 related articles for article (PubMed ID: 23266571)
1. Understanding genomic alterations in cancer genomes using an integrative network approach. Wang E Cancer Lett; 2013 Nov; 340(2):261-9. PubMed ID: 23266571 [TBL] [Abstract][Full Text] [Related]
2. Cancer omics: from regulatory networks to clinical outcomes. Tang B; Hsu PY; Huang TH; Jin VX Cancer Lett; 2013 Nov; 340(2):277-83. PubMed ID: 23201140 [TBL] [Abstract][Full Text] [Related]
3. Whole-exome sequencing reveals recurrent somatic mutation networks in cancer. Liu X; Wang J; Chen L Cancer Lett; 2013 Nov; 340(2):270-6. PubMed ID: 23153794 [TBL] [Abstract][Full Text] [Related]
4. Sequencing the transcriptional network of androgen receptor in prostate cancer. Chng KR; Cheung E Cancer Lett; 2013 Nov; 340(2):254-60. PubMed ID: 23196061 [TBL] [Abstract][Full Text] [Related]
5. Next generation sequencing reveals genetic landscape of hepatocellular carcinomas. Li S; Mao M Cancer Lett; 2013 Nov; 340(2):247-53. PubMed ID: 23063663 [TBL] [Abstract][Full Text] [Related]
6. Comprehensive genome sequencing of the liver cancer genome. Nakagawa H; Shibata T Cancer Lett; 2013 Nov; 340(2):234-40. PubMed ID: 23142287 [TBL] [Abstract][Full Text] [Related]
7. Next generation sequencing applications in cancer research. Zhang W; Nykter M; Chen K Cancer Lett; 2013 Nov; 340(2):149-50. PubMed ID: 23764479 [No Abstract] [Full Text] [Related]
8. Cancer heterogeneity and "the struggle for existence": diagnostic and analytical challenges. Horswell S; Matthews N; Swanton C Cancer Lett; 2013 Nov; 340(2):220-6. PubMed ID: 23142290 [TBL] [Abstract][Full Text] [Related]
9. Opportunities and methods for studying alternative splicing in cancer with RNA-Seq. Feng H; Qin Z; Zhang X Cancer Lett; 2013 Nov; 340(2):179-91. PubMed ID: 23196057 [TBL] [Abstract][Full Text] [Related]
10. Predictive genomics: a cancer hallmark network framework for predicting tumor clinical phenotypes using genome sequencing data. Wang E; Zaman N; Mcgee S; Milanese JS; Masoudi-Nejad A; O'Connor-McCourt M Semin Cancer Biol; 2015 Feb; 30():4-12. PubMed ID: 24747696 [TBL] [Abstract][Full Text] [Related]
12. Beyond microRNA--novel RNAs derived from small non-coding RNA and their implication in cancer. Martens-Uzunova ES; Olvedy M; Jenster G Cancer Lett; 2013 Nov; 340(2):201-11. PubMed ID: 23376637 [TBL] [Abstract][Full Text] [Related]
13. Genomic sequencing in cancer. Tuna M; Amos CI Cancer Lett; 2013 Nov; 340(2):161-70. PubMed ID: 23178448 [TBL] [Abstract][Full Text] [Related]
14. Cancer genome sequencing: understanding malignancy as a disease of the genome, its conformation, and its evolution. Patel LR; Nykter M; Chen K; Zhang W Cancer Lett; 2013 Nov; 340(2):152-60. PubMed ID: 23111104 [TBL] [Abstract][Full Text] [Related]
15. Next-generation sequencing in the clinic: promises and challenges. Xuan J; Yu Y; Qing T; Guo L; Shi L Cancer Lett; 2013 Nov; 340(2):284-95. PubMed ID: 23174106 [TBL] [Abstract][Full Text] [Related]
16. Cancer genomics and pathology: all together now. Shibata T Pathol Int; 2012 Oct; 62(10):647-59. PubMed ID: 23005591 [TBL] [Abstract][Full Text] [Related]
17. Implementing genomic medicine in pathology. Williams ES; Hegde M Adv Anat Pathol; 2013 Jul; 20(4):238-44. PubMed ID: 23752086 [TBL] [Abstract][Full Text] [Related]
18. Trastuzumab and beyond: sequencing cancer genomes and predicting molecular networks. Roukos DH Pharmacogenomics J; 2011 Apr; 11(2):81-92. PubMed ID: 20975737 [TBL] [Abstract][Full Text] [Related]